Ytterbium Yb 169 Dtpa

   
Google
 
Web NewDrugInformation.com

Ytterbium Yb 169 Dtpa


Drug - Ytterbium Yb 169 Dtpa
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pentetate Calcium Trisodium Yb-169
Multiple ingredients are in alphabetical order.

Strength - 2mCi/ML
The potency of the active ingredient(s), Pentetate Calcium Trisodium Yb-169. May repeat for multiple part products.

Applicant - 3M
The firm name holding legal responsibility for Ytterbium Yb 169 Dtpa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017518
The FDA assigned number to Ytterbium Yb 169 Dtpa. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ytterbium Yb 169 Dtpa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Ytterbium Yb 169 Dtpa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ytterbium Yb 169 Dtpa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Ytterbium Yb 169 Dtpa is in. Format is RX, OTC, DISCN.

Applicant Full Name - 3m Medical Products Div
The full name of the firm holding legal responsibility for the new application of Ytterbium Yb 169 Dtpa.

Ytterbium Yb 169 Dtpa